297例圆锥动脉干畸形胎儿的产前诊断与临床结局
回顾性分析2011年1月1日至2019年12月31日广州市妇女儿童医疗中心297例因圆锥动脉干畸形(CTD)行介入性产前诊断的胎儿,染色体异常率为17.5%(52/297),单纯型与非单纯型分别为10.4%(14/134)和23.3%(38/163)(χ²=8.428,P=0.004),结论推荐染色体微阵列分析(CMA)作为CTD首选遗传学检测手段。
要点
- CTD胎儿染色体异常率为17.5%(52/297),永存动脉干最高(7/14),大动脉转位最低5.2%(4/77)。
- 非单纯型CTD染色体异常率23.3%(38/163)高于单纯型10.4%(14/134),差异有统计学意义(P=0.004)。
- 同时合并心内心外畸形组染色体异常率最高37.8%(14/37),单纯组最低10.4%(14/134)。
核心结论
- CTD胎儿染色体异常概率高,同时发生心内心外畸形的胎儿更容易有染色体异常。
- 推荐CMA技术作为CTD的首选遗传学检测手段。
- 除外染色体异常,大部分CTD胎儿预后良好。
研究设计与样本
- 回顾性分析2011年1月1日至2019年12月31日广州市妇女儿童医疗中心产前诊断中心因CTD行介入性产前诊断及染色体分析的胎儿297例。
- 按超声诊断分为法洛四联症109例、肺动脉(干)闭锁30例、大动脉转位77例、右心室双出口53例、永存动脉干14例、主动脉弓离断14例6个亚型。
- 按合并畸形分为单纯组134例、合并其他心内畸形组86例、合并心外畸形组20例、同时合并心内心外畸形组37例、仅合并超声软指标异常组20例,后4组统称非单纯型CTD。
主要发现
- 297例CTD胎儿染色体异常率为17.5%(52/297),其中染色体数目异常21例、致病性拷贝数变异(CNV)28例、嵌合体3例。
- 19例CNV<5 Mb的微小致病性片段均由染色体微阵列分析(CMA)技术检出。
- 单纯型与非单纯型CTD胎儿染色体异常率分别为10.4%(14/134)和23.3%(38/163),两组比较差异有统计学意义(χ²=8.428,P=0.004)。
- 各亚型中永存动脉干染色体异常率最高,为7/14;大动脉转位最低,为5.2%(4/77)。
- 各组中同时合并心内心外畸形组染色体异常率最高,为37.8%(14/37);单纯组最低,为10.4%(14/134)。
关键数值与推荐
- CTD胎儿染色体异常率为17.5%(52/297)。
- 单纯型CTD染色体异常率为10.4%(14/134),非单纯型为23.3%(38/163),差异有统计学意义(χ²=8.428,P=0.004)。
- 永存动脉干染色体异常率为7/14,大动脉转位为5.2%(4/77)。
- 同时合并心内心外畸形组染色体异常率为37.8%(14/37),单纯组为10.4%(14/134)。
- 单纯组各亚型染色体异常率比较差异均无统计学意义(P均>0.05)。
临床怎么用
- 作者推荐CMA技术作为CTD的首选遗传学检测手段。
- 作者结论指出除外染色体异常,大部分CTD胎儿预后良好。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To analyze the prenatal diagnosis results and pregnancy outcomes of conotruncal defects (CTD) fetuses, and to explore the correlation between the CTD and chromosome diseases. Methods: A total of 297 cases of invasive prenatal diagnosis and chromosome analysis were collected at the Prenatal Diagnosis Center of Guangzhou Women and Children's Medical Center due to CTD from January 1st, 2011 to December 31th, 2019. According to ultrasonic diagnosis, CTD fetuses were divided into 6 subtypes: tetralogy of Fallot (109 cases), pulmonary atresia (30 cases), transposition of the great arteries (77 cases), double outlet right ventricle (53 cases), truncus arteriosus (14 cases) and interrupted aortic arch (14 cases). According to whether they were combined with intracardiac or extracardiac abnormalities, they were divided into simple group (134 cases), combined with other intracardiac abnormalities group (86 cases), combined with extracardiac abnormalities group (20 cases), combined with intracardiac and extracardiac abnormalities group (37 cases) and only combined with ultrasound soft marker group (20 cases), the last 4 groups were referred as non-simple types. The chromosome test results and pregnancy outcomes of each type and group were analyzed retrospectively. Results: Among the 297 CTD fetuses, the chromosome abnormality rate was 17.5% (52/297). There were 21 cases of abnormal chromosome number, 28 cases of pathogenetic copy number variantions and 3 cases of mosaics. All the 19 cases of micropathogenic fragments smaller than 5 Mb were detected by chromosomal microarray analysis (CMA). Among all the subtypes of CTD, the chromosomal abnormality rate of truncus arteriosus was the highest, at 7/14; while the rate of transposition of the great arteries was the lowest, at 5.2% (4/77). There were significant differences in the rate of chromosomal abnormalities between simple and non-simple types [10.4% (14/134) vs 23.3% (38/163); χ²=8.428, P=0.004]. In each group, the chromosomal abnormality rate was the highest in the combined with intracardiac and extracardiac abnormalities group, at 37.8% (14/37), and the lowest in the simple group, at 10.4% (14/134). There was no significant difference in the rate of chromosomal abnormalities in all subtypes of simple group (all P>0.05). Among 112 cases of live birth, 1 case was 22q11.2 microdeletion syndrome, 5 cases of postnatal clinical diagnosis and prenatal ultrasound diagnosis were not completely consistent, 5 cases died after birth. Conclusions: The incidence of chromosomal abnormalities is high in fetuses with CTD. CTD fetuses with concurrent extrapardiac malformations are more likely to incorporate chromosomal abnormalities. CMA technology could be used as a first-line genetic detection method for CTD. After excluding chromosomal abnormalities, most of the children with CTD have good prognosis. 目的: 分析圆锥动脉干畸形(CTD)胎儿的产前诊断结果及临床结局,探讨CTD与染色体异常的相关性。 方法: 收集2011年1月1日至2019年12月31日在广州市妇女儿童医疗中心产前诊断中心因CTD进行介入性产前诊断及染色体分析的胎儿297例。根据超声诊断将CTD胎儿分为法洛四联症(109例)、肺动脉(干)闭锁(30例)、大动脉转位(77例)、右心室双出口(53例)、永存动脉干(14例)、主动脉弓离断(14例)6个亚型;根据是否合并心内或心外畸形,分为单纯组(134例)、合并其他心内畸形组(86例)、合并心外畸形组(20例)、同时合并心内心外畸形组(37例)、仅合并超声软指标异常组(20例)5组,后4组统称非单纯型CTD。回顾性分析CTD各亚型、各组的染色体检测结果和妊娠结局。 结果: 297例CTD胎儿中,染色体异常率为17.5%(52/297),其中染色体数目异常21例,致病性拷贝数变异28(CNV)例,嵌合体3例。19例CNV <5 Mb的微小致病性片段均由染色体微阵列分析(CMA)技术检出。单纯型与非单纯型CTD胎儿的染色体异常率分别为10.4%(14/134)和23.3%(38/163),两组比较,差异有统计学意义(χ²=8.428,P=0.004)。各亚型CTD胎儿中,永存动脉干者的染色体异常率最高,为7/14;大动脉转位者的染色体异常率最低,为5.2%(4/77)。各组CTD胎儿中,同时合并心内心外畸形组染色体异常率最高,为37.8%(14/37);单纯组染色体异常率最低,为10.4%(14/134)。单纯组各亚型CTD胎儿的染色体异常率分别比较,差异均无统计学意义(P均>0.05)。112例活产患儿中,22q11.2微缺失综合征1例,出生后临床诊断与产前超声诊断不完全一致5例,出生后死亡5例。 结论: CTD胎儿的染色体异常概率高,同时发生心内心外畸形的胎儿更容易有染色体异常,推荐CMA技术作为CTD的首选遗传学检测手段。除外染色体异常,大部分CTD胎儿预后良好。.
引用
- Cao Q, Xu LL, Li R, et al. [Prenatal diagnosis and clinical outcomes of 297 fetuses with conotruncal defects]. Zhonghua Fu Chan Ke Za Zhi. 2022. PMID: 35090242. doi:10.3760/cma.j.cn112141-20210617-00329
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。